The Hyakujushi Bank, Ltd. (TYO:8386)

Revance Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	780,216	861,929	1,080,562	1,197,854	1,115,997	893,016
Investment Securities	1,185,869	1,215,420	1,158,487	1,079,615	1,303,322	1,296,541
Trading Asset Securities	-	-	-	9	-	13
Total Investments	1,185,869	1,215,420	1,158,487	1,079,624	1,303,322	1,296,554
Gross Loans	3,557,732	3,508,289	3,434,191	3,362,245	3,169,619	3,035,782
Allowance for Loan Losses	-17,965	-18,289	-17,298	-17,514	-18,285	-18,172
Net Loans	3,539,767	3,490,000	3,416,893	3,344,731	3,151,334	3,017,610
Property, Plant & Equipment	37,469	37,520	37,348	36,867	37,134	37,368
Other Intangible Assets	6,136	5,407	4,841	4,406	4,654	5,041
Other Current Assets	22,307	22,075	24,601	39,836	29,117	31,367
Long-Term Deferred Tax Assets	732	732	722	732	737	777
Other Long-Term Assets	130,188	120,500	117,196	105,309	104,971	93,836
Total Assets	5,702,684	5,753,583	5,840,650	5,809,359	5,747,266	5,375,569
Accrued Expenses	-	70	58	49	57	20
Interest Bearing Deposits	4,743,208	4,695,040	4,749,635	4,780,670	4,632,815	4,525,292
Total Deposits	4,743,208	4,695,040	4,749,635	4,780,670	4,632,815	4,525,292
Short-Term Borrowings	10,985	8,286	15,673	20,360	23,254	12,089
Other Current Liabilities	18,718	17,702	19,808	19,898	22,881	21,938
Long-Term Debt	497,219	613,505	615,210	624,432	713,311	449,974
Pension & Post-Retirement Benefits	307	309	311	286	247	253
Long-Term Deferred Tax Liabilities	25,759	22,983	26,473	8,125	11,257	17,156
Other Long-Term Liabilities	69,655	67,416	84,297	74,441	59,109	57,150
Total Liabilities	5,365,851	5,425,311	5,511,465	5,528,261	5,462,931	5,083,872
Common Stock	37,322	37,322	37,322	37,322	37,322	37,322
Additional Paid-In Capital	30,486	30,486	30,486	30,486	30,486	30,486
Retained Earnings	207,346	204,899	194,802	187,908	183,444	173,620
Treasury Stock	-536	-565	-569	-513	-2,030	-2,071
Comprehensive Income & Other	62,215	56,130	67,144	25,895	35,113	52,340
Total Common Equity	336,833	328,272	329,185	281,098	284,335	291,697
Shareholders' Equity	336,833	328,272	329,185	281,098	284,335	291,697
Total Liabilities & Equity	5,702,684	5,753,583	5,840,650	5,809,359	5,747,266	5,375,569
Total Debt	508,204	621,791	630,883	644,792	736,565	462,063
Net Cash (Debt)	272,012	240,138	449,679	553,071	379,432	430,966
Net Cash Growth	-30.64%	-46.60%	-18.69%	45.76%	-11.96%	116.65%
Net Cash Per Share	9564.78	8434.18	15676.45	19024.18	12862.97	14603.57
Filing Date Shares Outstanding	28.42	28.42	28.56	28.92	29.36	29.48
Total Common Shares Outstanding	28.42	28.42	28.56	28.92	29.49	29.48
Book Value Per Share	11851.83	11550.59	11527.77	9720.06	9640.62	9893.87
Tangible Book Value	330,697	322,865	324,344	276,692	279,681	286,656
Tangible Book Value Per Share	11635.93	11360.34	11358.24	9567.70	9482.82	9722.89

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.